(18)F-FDOPA PET/MRI for monitoring early response to bevacizumab in children with recurrent brain tumors

BACKGROUND: Noninvasively predicting early response to therapy in recurrent pediatric brain tumors provides a challenge. 3,4-dihydroxy-6-[(18)F]fluoro-L-phenylalanine ((18)F-FDOPA) PET/MRI has not been previously studied as a tool to evaluate early response to antiangiogenic therapy in children. The...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurooncol Pract
Autors principals: Gauvain, Karen, Ponisio, Maria Rosana, Barone, Amy, Grimaldi, Michael, Parent, Ephraim, Leeds, Hayden, Goyal, Manu, Rubin, Joshua, McConathy, Jonathan
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5909807/
https://ncbi.nlm.nih.gov/pubmed/29692922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nop/npx008
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars